Home > 暂无记录 暂无记录 行业新闻

行业新闻


  • Dexamethasone EY0013

    Dexamethasone (DEX), a synthetic glucocorticoid, is widely used in clinical settings for its anti-inflammatory effect. Dexamethasone (DHAP)是一种抗炎剂和免疫抑制剂。

    More
  • Sorafenib EY0017

    Sorafenib (BAY 43-9006), an orally active multi-kinase inhibitor, targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Sorafenib是Raf-1, B-Raf和VEGFR-2等的多重激酶抑制剂,IC50分别为6 nM, 22 nM和90 nM。

    More
  • Vismodegib EY0025

    Vismodegib (GDC-0449)是一种有效的,新型的,特异性的hedgehog抑制剂,IC50为3 nM。GDC-0449也抑制P-gp作用,IC50为3.0μM。

    More
  • Enzalutamide EY0026

    Enzalutamide, an AR signaling inhibitor, is effective for bicalutamide-resistant tumors and has been used in metastatic castration-resistant prostate cancer. Enzalutamide (MDV3100)是一种雄激素受体(AR)拮抗剂,IC50为36 nM。

    More
  • Docetaxel EY0027

    Docetaxel, a cytotoxic antimicrotuble agent, is frequently administrated as a first line treatment for prostate cancers. Docetaxel,一种紫杉醇类似物,通过结合到稳定的微管来抑制微管解聚。

    More
  • Current page237, Total Pages313, Total Record1562 First Prev 235236237238239 Next Last Goto